SUN3 activators pertain to a category of chemical agents that modulate the activity of a specific subset of proteins or cellular mechanisms identified as 'SUN3.' The 'SUN' in their name often denotes a specific characteristic or functional domain within the proteins they target, which could be an acronym found in a more technical, scientific nomenclature. These activators are designed to interact precisely with their target sites, initiating a cascade of biochemical interactions. The chemical structure of SUN3 activators typically features molecular moieties that enable them to engage with the active or allosteric sites of SUN3 proteins. This engagement is achieved through non-covalent interactions such as hydrogen bonding, van der Waals forces, and hydrophobic effects, which contribute to the specificity and selectivity of these activators toward their intended targets.
The development and investigation of SUN3 activators involve a rigorous process of chemical synthesis, characterization, and analysis. Researchers utilize various techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry to elucidate the structural details of these compounds. Such detailed structural information is crucial for understanding the mechanism of action at the molecular level. The molecular framework of SUN3 activators is often optimized through iterative processes of structure-activity relationship (SAR) studies, allowing chemists to refine the efficacy and specificity of these compounds. The physical properties of SUN3 activators, such as solubility, stability, and permeability, are also fine-tuned to ensure that they can effectively reach and interact with their target sites within a given context. Through these comprehensive studies, the precise function and role of SUN3 within the biochemical pathways can be better understood, paving the way for advanced research into the modulation of these specific proteins or processes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly activates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA which can phosphorylate various proteins, potentially including SUN3, thus enhancing its functional activity within the cell. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation leads to downstream phosphorylation events, which may include the phosphorylation and consequent activation of SUN3. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, leading to activation of calcium-dependent signaling pathways. This influx of calcium can influence the functional activity of SUN3 by modulating its binding to calcium-sensitive partner proteins. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol from green tea, is known for its kinase inhibitory activity. By inhibiting certain kinases, EGCG could reduce competitive phosphorylation, potentially allowing for increased phosphorylation and activation of SUN3 by its specific kinases. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that alters the PI3K/Akt pathway. Downregulation of this pathway may lead to a compensatory increase in other signaling pathways that could include the activation of SUN3. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, leading to diverse signaling cascades that can include cytoskeletal rearrangement and may involve the functional activation of SUN3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. This can activate calcium-dependent signaling mechanisms that may enhance the activity of SUN3. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, but it can lead to selective activation of signaling pathways by inhibiting overactive kinases, potentially leading to an increased activity of SUN3. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the function of SUN3 through calcium-dependent pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell, which could result in enhanced activity of SUN3 if it is regulated by phosphorylation. | ||||||